Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Skull Fractures | 3 | 2022 | 202 | 2.030 |
Why?
|
Surgery, Plastic | 4 | 2024 | 643 | 1.290 |
Why?
|
Mammaplasty | 6 | 2024 | 1240 | 0.910 |
Why?
|
Breast Implants | 2 | 2024 | 410 | 0.850 |
Why?
|
Public Opinion | 3 | 2022 | 481 | 0.750 |
Why?
|
Surgical Equipment | 1 | 2021 | 57 | 0.750 |
Why?
|
Clothing | 1 | 2021 | 97 | 0.730 |
Why?
|
Schwann Cells | 1 | 2021 | 196 | 0.730 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2023 | 791 | 0.660 |
Why?
|
Muscular Atrophy | 1 | 2021 | 331 | 0.630 |
Why?
|
Neck Injuries | 1 | 2019 | 160 | 0.570 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2022 | 694 | 0.530 |
Why?
|
Spinal Injuries | 1 | 2019 | 300 | 0.510 |
Why?
|
Physician's Role | 1 | 2021 | 918 | 0.470 |
Why?
|
Prostheses and Implants | 1 | 2021 | 1273 | 0.460 |
Why?
|
Staphylococcal Infections | 1 | 2022 | 1407 | 0.440 |
Why?
|
Cross Infection | 1 | 2022 | 1434 | 0.440 |
Why?
|
Equipment Design | 1 | 2021 | 3520 | 0.420 |
Why?
|
Stem Cell Transplantation | 1 | 2021 | 1601 | 0.420 |
Why?
|
Cervical Vertebrae | 1 | 2019 | 978 | 0.410 |
Why?
|
Mesenchymal Stem Cells | 1 | 2021 | 1634 | 0.370 |
Why?
|
Cosmetic Techniques | 2 | 2024 | 148 | 0.360 |
Why?
|
Burns | 1 | 2021 | 1866 | 0.340 |
Why?
|
Anastomosis, Surgical | 4 | 2024 | 983 | 0.300 |
Why?
|
Health Personnel | 1 | 2021 | 3310 | 0.290 |
Why?
|
Biomedical Research | 1 | 2023 | 3426 | 0.290 |
Why?
|
Pediatrics | 1 | 2021 | 3586 | 0.270 |
Why?
|
Telemedicine | 5 | 2021 | 3018 | 0.260 |
Why?
|
Microsurgery | 3 | 2023 | 796 | 0.210 |
Why?
|
Physicians | 1 | 2021 | 4591 | 0.210 |
Why?
|
Durapatite | 1 | 2024 | 163 | 0.210 |
Why?
|
Nipples | 1 | 2024 | 221 | 0.200 |
Why?
|
Polyesters | 1 | 2024 | 372 | 0.200 |
Why?
|
Mandibular Fractures | 1 | 2022 | 76 | 0.200 |
Why?
|
Esthetics | 1 | 2024 | 326 | 0.200 |
Why?
|
Methicillin Resistance | 1 | 2022 | 199 | 0.200 |
Why?
|
Financing, Organized | 1 | 2023 | 204 | 0.190 |
Why?
|
Median Nerve | 1 | 2021 | 132 | 0.190 |
Why?
|
Body Surface Area | 1 | 2021 | 197 | 0.190 |
Why?
|
Needles | 1 | 2024 | 451 | 0.190 |
Why?
|
46, XX Disorders of Sex Development | 1 | 2021 | 34 | 0.180 |
Why?
|
Hyaluronic Acid | 1 | 2024 | 482 | 0.180 |
Why?
|
Mullerian Ducts | 1 | 2021 | 201 | 0.170 |
Why?
|
Rats, Inbred Lew | 1 | 2021 | 1154 | 0.170 |
Why?
|
Breast Implantation | 1 | 2022 | 223 | 0.170 |
Why?
|
Facial Transplantation | 1 | 2022 | 221 | 0.170 |
Why?
|
Femoral Artery | 1 | 2023 | 831 | 0.160 |
Why?
|
Kynurenine | 1 | 2019 | 139 | 0.160 |
Why?
|
Baltimore | 1 | 2019 | 230 | 0.160 |
Why?
|
Humans | 37 | 2024 | 760613 | 0.160 |
Why?
|
Skull | 1 | 2022 | 815 | 0.150 |
Why?
|
Photography | 1 | 2021 | 530 | 0.150 |
Why?
|
Ubiquinone | 1 | 2019 | 183 | 0.150 |
Why?
|
Physician-Patient Relations | 2 | 2021 | 3242 | 0.140 |
Why?
|
Ownership | 1 | 2019 | 339 | 0.140 |
Why?
|
Uterus | 1 | 2021 | 651 | 0.140 |
Why?
|
Male | 13 | 2024 | 359718 | 0.140 |
Why?
|
Female | 20 | 2024 | 391246 | 0.140 |
Why?
|
Upper Extremity | 1 | 2021 | 661 | 0.140 |
Why?
|
Trust | 1 | 2021 | 532 | 0.130 |
Why?
|
Body Dysmorphic Disorders | 1 | 2020 | 243 | 0.130 |
Why?
|
Cues | 1 | 2021 | 867 | 0.130 |
Why?
|
Fracture Fixation, Internal | 1 | 2022 | 963 | 0.130 |
Why?
|
Congenital Abnormalities | 1 | 2021 | 704 | 0.130 |
Why?
|
Vascular Patency | 3 | 2024 | 901 | 0.130 |
Why?
|
Nerve Regeneration | 1 | 2021 | 790 | 0.130 |
Why?
|
Retrospective Studies | 7 | 2024 | 80345 | 0.130 |
Why?
|
Physicians, Women | 1 | 2021 | 495 | 0.120 |
Why?
|
Quality-Adjusted Life Years | 1 | 2021 | 1723 | 0.120 |
Why?
|
Infertility, Female | 1 | 2021 | 759 | 0.120 |
Why?
|
Vascular Surgical Procedures | 1 | 2023 | 1469 | 0.120 |
Why?
|
Child, Preschool | 3 | 2022 | 42056 | 0.110 |
Why?
|
Self Care | 1 | 2019 | 793 | 0.110 |
Why?
|
Risk Reduction Behavior | 1 | 2020 | 1109 | 0.110 |
Why?
|
Secondary Prevention | 1 | 2019 | 1548 | 0.100 |
Why?
|
Social Support | 1 | 2021 | 2145 | 0.100 |
Why?
|
Occupational Exposure | 1 | 2022 | 1809 | 0.100 |
Why?
|
Myocardial Infarction | 3 | 2021 | 11890 | 0.100 |
Why?
|
Breast Neoplasms | 3 | 2024 | 21029 | 0.100 |
Why?
|
Prospective Studies | 4 | 2022 | 54306 | 0.090 |
Why?
|
Migraine Disorders | 1 | 2023 | 1693 | 0.090 |
Why?
|
Organ Transplantation | 1 | 2021 | 1150 | 0.090 |
Why?
|
Caenorhabditis elegans | 1 | 2019 | 1444 | 0.090 |
Why?
|
Artificial Intelligence | 2 | 2021 | 2557 | 0.090 |
Why?
|
United States | 6 | 2023 | 72448 | 0.090 |
Why?
|
Caregivers | 1 | 2021 | 2224 | 0.080 |
Why?
|
Stents | 1 | 2021 | 3303 | 0.080 |
Why?
|
Intensive Care Units | 1 | 2022 | 3736 | 0.080 |
Why?
|
Societies, Medical | 1 | 2021 | 3905 | 0.080 |
Why?
|
Cardiology | 1 | 2020 | 1723 | 0.080 |
Why?
|
Child | 3 | 2022 | 79799 | 0.080 |
Why?
|
Heart Diseases | 1 | 2021 | 2809 | 0.080 |
Why?
|
Length of Stay | 1 | 2021 | 6476 | 0.070 |
Why?
|
Adult | 8 | 2024 | 220007 | 0.070 |
Why?
|
Heart | 1 | 2020 | 4393 | 0.070 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 4924 | 0.070 |
Why?
|
Cells, Cultured | 1 | 2021 | 18955 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 3332 | 0.060 |
Why?
|
Rats | 1 | 2021 | 23709 | 0.060 |
Why?
|
Outpatients | 2 | 2024 | 1607 | 0.060 |
Why?
|
Mastectomy | 2 | 2024 | 1832 | 0.060 |
Why?
|
Arteriovenous Anastomosis | 1 | 2024 | 14 | 0.060 |
Why?
|
Perception | 2 | 2022 | 1195 | 0.060 |
Why?
|
Cardiovascular Diseases | 2 | 2020 | 15760 | 0.060 |
Why?
|
Cell Differentiation | 1 | 2021 | 11481 | 0.060 |
Why?
|
Breast | 2 | 2023 | 1963 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3386 | 0.060 |
Why?
|
Postoperative Complications | 5 | 2024 | 15679 | 0.060 |
Why?
|
Swine | 2 | 2024 | 5899 | 0.060 |
Why?
|
Epigastric Arteries | 1 | 2022 | 92 | 0.050 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18137 | 0.050 |
Why?
|
Mandibular Condyle | 1 | 2022 | 115 | 0.050 |
Why?
|
Administration, Cutaneous | 1 | 2024 | 713 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2023 | 64981 | 0.050 |
Why?
|
Patient Satisfaction | 2 | 2024 | 3448 | 0.050 |
Why?
|
Fracture Fixation | 1 | 2022 | 365 | 0.040 |
Why?
|
Skin | 2 | 2024 | 4466 | 0.040 |
Why?
|
Acute Disease | 2 | 2021 | 7268 | 0.040 |
Why?
|
Kynurenine 3-Monooxygenase | 1 | 2019 | 1 | 0.040 |
Why?
|
Animals | 5 | 2024 | 167960 | 0.040 |
Why?
|
Technology | 1 | 2021 | 291 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2022 | 5508 | 0.040 |
Why?
|
Subcutaneous Tissue | 1 | 2019 | 132 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2019 | 26179 | 0.040 |
Why?
|
Hydrolases | 1 | 2019 | 146 | 0.040 |
Why?
|
Personality | 1 | 2022 | 552 | 0.040 |
Why?
|
Markov Chains | 1 | 2021 | 968 | 0.040 |
Why?
|
Pilot Projects | 2 | 2023 | 8556 | 0.040 |
Why?
|
RNA, Double-Stranded | 1 | 2019 | 295 | 0.040 |
Why?
|
Nutritive Value | 1 | 2020 | 349 | 0.030 |
Why?
|
Infant | 1 | 2019 | 36053 | 0.030 |
Why?
|
Patient Preference | 1 | 2024 | 922 | 0.030 |
Why?
|
Microscopy | 1 | 2021 | 885 | 0.030 |
Why?
|
Methyltransferases | 1 | 2019 | 374 | 0.030 |
Why?
|
Propensity Score | 1 | 2024 | 1926 | 0.030 |
Why?
|
Brazil | 1 | 2020 | 1212 | 0.030 |
Why?
|
Patient Readmission | 2 | 2021 | 3322 | 0.030 |
Why?
|
Monitoring, Ambulatory | 1 | 2019 | 353 | 0.030 |
Why?
|
Face | 1 | 2022 | 1017 | 0.030 |
Why?
|
American Heart Association | 1 | 2020 | 1081 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2019 | 1544 | 0.030 |
Why?
|
Aftercare | 1 | 2021 | 916 | 0.030 |
Why?
|
Appointments and Schedules | 1 | 2019 | 442 | 0.030 |
Why?
|
Diffusion of Innovation | 1 | 2020 | 730 | 0.030 |
Why?
|
Adolescent | 2 | 2021 | 87809 | 0.030 |
Why?
|
History, 21st Century | 1 | 2020 | 1575 | 0.030 |
Why?
|
Reward | 1 | 2020 | 963 | 0.030 |
Why?
|
Middle Aged | 6 | 2024 | 220359 | 0.030 |
Why?
|
Primary Prevention | 1 | 2020 | 1207 | 0.030 |
Why?
|
Drug Delivery Systems | 1 | 2024 | 2221 | 0.030 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2019 | 866 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2019 | 2192 | 0.020 |
Why?
|
History, 20th Century | 1 | 2020 | 2773 | 0.020 |
Why?
|
Nutritional Status | 1 | 2020 | 1607 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2022 | 5201 | 0.020 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2019 | 936 | 0.020 |
Why?
|
Forecasting | 1 | 2020 | 2931 | 0.020 |
Why?
|
RNA Interference | 1 | 2019 | 2846 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 25941 | 0.020 |
Why?
|
Decision Making | 1 | 2023 | 3925 | 0.020 |
Why?
|
Risk Factors | 3 | 2021 | 74333 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2019 | 2315 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2020 | 3300 | 0.020 |
Why?
|
Patient Discharge | 1 | 2021 | 3474 | 0.020 |
Why?
|
Logistic Models | 1 | 2022 | 13312 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2020 | 3185 | 0.020 |
Why?
|
Pain | 1 | 2022 | 5066 | 0.020 |
Why?
|
Medication Adherence | 1 | 2019 | 2165 | 0.020 |
Why?
|
Health Status | 1 | 2020 | 4082 | 0.020 |
Why?
|
Mitochondria | 1 | 2019 | 3601 | 0.020 |
Why?
|
Clinical Competence | 1 | 2021 | 4783 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10343 | 0.010 |
Why?
|
Exercise | 1 | 2020 | 5787 | 0.010 |
Why?
|
Research Design | 1 | 2019 | 6180 | 0.010 |
Why?
|
Hospitalization | 1 | 2019 | 10789 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 24102 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40139 | 0.010 |
Why?
|
Aged | 2 | 2019 | 169143 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 58748 | 0.010 |
Why?
|
Concepts
(179)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_